Comparing stroke prevention therapy of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: a nationwide retrospective observational study

Direct oral anticoagulants (DOACs) are not only increasingly being used for the initial stroke prevention therapy but progressively also substitute vitamin K antagonist (VKA) treatment in patients with non-val...

Source: BMC Medicine - August 27, 2020 Category: Internal Medicine Authors: Lena M. Paschke, Kerstin Klimke, Attila Altiner, Dominik von Stillfried and Maike Schulz Tags: Research article Source Type: research